Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Cash from Operations (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Cash from Operations for 4 consecutive years, with 14149000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations rose 52.85% year-over-year to 14149000.0; the TTM value through Dec 2025 reached 103757000.0, down 32.83%, while the annual FY2025 figure was 103757000.0, 32.83% down from the prior year.
  • Cash from Operations was 14149000.0 for Q4 2025 at Day One Biopharmaceuticals, down from 5805000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 50753000.0 in Q3 2024, with the low at 58997000.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 27412312.5 across 4 years, with a median of 29897500.0 in 2022.
  • The largest annual shift saw Cash from Operations skyrocketed 236.93% in 2024 before it crashed 111.44% in 2025.
  • Over 4 years, Cash from Operations stood at 35310000.0 in 2022, then dropped by 17.17% to 41372000.0 in 2023, then increased by 27.47% to 30008000.0 in 2024, then soared by 52.85% to 14149000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 14149000.0 in Q4 2025, 5805000.0 in Q3 2025, and 24806000.0 in Q2 2025.